Homepage > Company > Media > Pharma News > 2019 > France has no plans to legalize cannabis for recreational use: minister

France has no plans to legalize cannabis for recreational use: minister

PARIS (Reuters) - France will not legalize the recreational use of cannabis but could consider authorizing its medical use, Transport Minister Elisabeth Borne said on Thursday.

“The position of the French state is clear. We are against legalizing cannabis for recreational use. There is an ongoing discussion about a medical use,” Borne told LCI television.

Borne’s comments follow publication of a report on Thursday by French think-tank the Conseil d’Analyse Economique recommending legalizing cannabis for recreational use in France.

Several countries, including Germany, Italy and Denmark, already allow the prescription of medical cannabis and last year Canada became the second country in the world to fully legalize marijuana.

In France, GreenLeaf, a French hemp-based and cannabis healthcare company, recently said it had agreed to be bought by rival EMMAC Life Sciences Ltd, as the legal use of cannabis for medicinal purposes grows further.

JUNE 20, 2019

https://www.reuters.com/

Read also

EC approves AstraZeneca’s Fasenra for EGPA treatment

The European Commission (EC) has approved AstraZeneca‘s Fasenra (benralizumab) as an add-on therapy for adults with relapsing or refractory eosinophilic granulomatosis with polyangii...

Genprex reports positive preclinical gene therapy data

Genprex, Inc., a clinical-stage gene therapy company, announced positive preclinical results for its lead drug candidate, Reqorsa® (quratusugene ozeplasmid) Gene Therapy, at the recent EORTC-...

Astellas withdraws Europe ACP application for AMD treatment

Astellas Pharma has announced the withdrawal of its marketing authorisation application for IZERVAY (avacincaptad pegol, ACP) intravitreal solution to treat geographic atrophy (GA) sec...

New report demands greater understanding of the impact of change on academia

Digital Science, a technology company serving stakeholders across the research ecosystem, is today calling for greater awareness of the impact that a myriad of fast-developing technologies are having ...